1-氨甲基-5-甲氧基茚满

1-氨甲基-5-甲氧基茚满（英语：，简称AMMI），是一种由普渡大学的大卫·厄尔·尼科尔斯领导的团队开发的药物，它作为选择性血清素释放剂并与和DiFMDA具有相似亲和力的血清素转运蛋白结合。[1][2]

1-氨甲基-5-甲氧基茚满
臨床資料
给药途径口服
ATC碼
  • 未分配
法律規範狀態
法律規範
  • 失控
识别
  • (5-Methoxy-2,3-dihydro-1H-inden-1-yl)methanamine
CAS号1415750-28-5  ☒N
PubChem CID
ChemSpider
UNII
化学
化学式C11H15NO
摩尔质量177.25 g·mol−1
3D模型（JSmol）
  • NCC1CCc2c1ccc(OC)c2
  • InChI=1S/C11H15NO/c1-13-10-4-5-11-8(6-10)2-3-9(11)7-12/h4-6,9H,2-3,7,12H2,1H3 checkY
  • Key:WPBKCMLYKMDWRD-UHFFFAOYSA-N checkY

参见
  • 2CB-Ind

参考资料
  1. Roman DL, Saldaña SN, Nichols DE, Carroll FI, Barker EL. . The Journal of Pharmacology and Experimental Therapeutics. February 2004, 308 (2): 679–87. PMID 14593087. S2CID 6439942. doi:10.1124/jpet.103.057836.
  2. Walline CC, Nichols DE, Carroll FI, Barker EL. . The Journal of Pharmacology and Experimental Therapeutics. June 2008, 325 (3): 791–800. PMC 2637348 可免费查阅. PMID 18354055. doi:10.1124/jpet.108.136200.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.